Skip to content

GMP Guideline

Trusted GMP guidance written for real-world professionals

Tag: pharmaceutical manufacturing

  • Home
  • pharmaceutical manufacturing
  • Page 70
Pharmaceutical GMP

Failure to Link Cold Chain and Storage Practices with Quality Systems

Failure to Link Cold Chain and Storage Practices with Quality Systems The Critical Connection Between…
GMP by Industry

Regulatory Risks from Weak Herbal Product GMP Implementation

Regulatory Risks from Weak Herbal Product GMP Implementation Understanding the Regulatory Challenges of Insufficient Herbal…
Quality Assurance under GMP

Failure to Apply Risk Based Decision Making in GMP Systems

Failure to Apply Risk Based Decision Making in GMP Systems Consequences of Neglecting Risk-Based Decision…
Validation and Qualification

Documentation Deficiencies in CPV Reports

Documentation Deficiencies in CPV Reports Understanding Documentation Gaps in Continued Process Verification Reports In the…
Pharmaceutical GMP

Regulatory Risks from Weak Cold Chain and Storage Practices Implementation

Regulatory Risks from Weak Cold Chain and Storage Practices Implementation Understanding the Regulatory Implications of…
GMP by Industry

Audit Findings Related to Herbal Product GMP Deficiencies

Audit Findings Related to Herbal Product GMP Deficiencies Identifying Deficiencies in Herbal Product GMP: Audit…
Quality Assurance under GMP

Regulatory Expectations for Implementation of ICH Q9

Regulatory Expectations for Implementation of ICH Q9 Understanding Regulatory Perspectives on Implementing ICH Q9 in…
Validation and Qualification

CPV Data Not Used to Trigger CAPA or Revalidation

CPV Data Not Used to Trigger CAPA or Revalidation Understanding CPV Data Exclusions for CAPA…
Pharmaceutical GMP

Audit Findings Related to Cold Chain and Storage Practices Deficiencies

Audit Findings Related to Cold Chain and Storage Practices Deficiencies Deficiencies Identified During Audits Concerning…
Quality Assurance under GMP

Core Concepts of Risk Evaluation in Pharmaceutical Industry

Core Concepts of Risk Evaluation in Pharmaceutical Industry Fundamental Principles of Risk Assessment in the…

Posts pagination

Previous 1 … 69 70 71 … 179 Next

Recent Posts

  • Weak Integration of Laboratory Practices with Quality Systems
  • Regulatory Risks from Weak QA Governance Systems
  • Documentation Gaps in GLP and GMP Records
  • Audit Observations Related to QA Oversight Failures
  • Failure to Align Lab Practices with Regulatory Expectations

Categories

  • Documentation and Data Integrity
  • Global GMP Guidelines
  • GMP Audits and Inspections
  • GMP Basics
  • GMP by Industry
  • Pharmaceutical GMP
  • Quality Assurance under GMP
  • Quality Control under GMP
  • SOPs
  • Training and Careers
  • Uncategorized
  • Validation and Qualification
Copyright © 2026 GMP Guideline Theme: Timely News By Artify Themes.